2-Me-DMT
Discover related
2 sources
How the databases line up — = agree, ≈ partial, ≠ differ. In lists, shared items appear in every source and unique ones in only one (matched case-insensitively).
| TripSit | TiHKAL | ||
|---|---|---|---|
| Classification | |||
| Class / category | — | ||
| Also known as | — | TRYPTAMINE, 2,N,N-TRIMETHYLINDOLE, 3-[2-(DIMETHYLAMINO)ETHYL]-2-METHYL2,N,N-TRIMETHYLTRYPTAMINE3-[2-(DIMETHYLAMINO)ETHYL]-2-METHYLINDOLEDESMETHOXY-INDAPEX | |
| Safety | |||
| Dose · Oral | |||
| Light | 30–50 mg | — | |
| Common | 50–75 mg | 50–100 mg | ≠ |
| Strong | 75–100 mg | — | |
| Duration | |||
| Total | 3–8 hours | 4–6 hours | ≠ |
| After-effects | 1–5 hours | — | |
Dose at a glance
Each database's primary-route ladder on one shared scale — see where ranges line up or shift.
Duration at a glance
Total duration on one shared scale.
TripSit summary
Also known as 2,N,N-TMT, this drug was first synthesised by Alexander Shulgin. Described as a very mild psychedelic of similar subjective effects to other tryptamines. Reported as having an unusual and unpredictable dose curve, it is recommended to start low with this drug.
TiHKAL summary
This compound does not read as a psychedelic or a cardiovascular stimulant, but rather as a kind of tactile enhancer that can heighten sexual pleasure. Aside from some sound distortion it seems relatively free of unpleasant side effects, and the 2-position methyl appears to grant it oral activity it would otherwise lack.
Fact-sheets from PsychonautWiki. Harm-reduction reference only — not medical advice.